CD274 and cancer: Studies have shown that PD-L1 is overexpressed in tumor cells in different types of cancers including HCC, which leads to an increase in binding between PD-L1 and PD-1 on T cells within the tumor microenvironment resulting in immune anergy and apoptosis [27,28].